Indian Pharma Market growth flat in Feb 2022
Price was the key driver for the period
Price was the key driver for the period
Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport
A total of 17 labs will be operational across the country by this month
Serina has over 17 years of experience in the biopharmaceutical industry
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry
Subscribe To Our Newsletter & Stay Updated